Literature DB >> 28375512

The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.

Latania K Logan1,2, Robert A Weinstein3,2.   

Abstract

Carbapenem-resistant Enterobacteriaceae (CRE) are a serious public health threat. Infections due to these organisms are associated with significant morbidity and mortality. Mechanisms of drug resistance in gram-negative bacteria (GNB) are numerous; β-lactamase genes carried on mobile genetic elements are a key mechanism for the rapid spread of antibiotic-resistant GNB worldwide. Transmissible carbapenem-resistance in Enterobacteriaceae has been recognized for the last 2 decades, but global dissemination of carbapenemase-producing Enterobacteriaceae (CPE) is a more recent problem that, once initiated, has been occurring at an alarming pace. In this article, we discuss the evolution of CRE, with a focus on the epidemiology of the CPE pandemic; review risk factors for colonization and infection with the most common transmissible CPE worldwide, Klebsiella pneumoniae carbapenemase-producing K. pneumoniae; and present strategies used to halt the striking spread of these deadly pathogens.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Enterobacteriaceae infections; adult; antibacterial agents; carbapenemases; carbapenems; child; drug resistance; epidemiology; global health; gram-negative bacteria

Mesh:

Substances:

Year:  2017        PMID: 28375512      PMCID: PMC5853342          DOI: 10.1093/infdis/jiw282

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  88 in total

1.  Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007.

Authors:  Mariana Castanheira; Lalitagauri M Deshpande; Dilip Mathai; Jan M Bell; Ronald N Jones; Rodrigo E Mendes
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

Review 2.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

3.  Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program.

Authors:  Robyn M Kaiser; Mariana Castanheira; Ronald N Jones; Fred Tenover; Ruth Lynfield
Journal:  Diagn Microbiol Infect Dis       Date:  2013-05-06       Impact factor: 2.803

4.  Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340).

Authors:  Polyana Silva Pereira; Carlos Felipe Machado de Araujo; Liliane Miyuki Seki; Viviane Zahner; Ana Paula D'Alincourt Carvalho-Assef; Marise Dutra Asensi
Journal:  J Antimicrob Chemother       Date:  2012-10-15       Impact factor: 5.790

5.  Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Authors:  L Poirel; T Naas; D Nicolas; L Collet; S Bellais; J D Cavallo; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

Review 6.  OXA-48-like carbapenemases: the phantom menace.

Authors:  Laurent Poirel; Anaïs Potron; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2012-04-11       Impact factor: 5.790

Review 7.  High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence.

Authors:  A Vatopoulos
Journal:  Euro Surveill       Date:  2008-01-24

Review 8.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

9.  The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

Authors:  Michael Y Lin; Rosie D Lyles-Banks; Karen Lolans; David W Hines; Joel B Spear; Russell Petrak; William E Trick; Robert A Weinstein; Mary K Hayden
Journal:  Clin Infect Dis       Date:  2013-08-14       Impact factor: 9.079

10.  Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.

Authors:  Latania K Logan; John P Renschler; Sumanth Gandra; Robert A Weinstein; Ramanan Laxminarayan
Journal:  Emerg Infect Dis       Date:  2015-11       Impact factor: 6.883

View more
  348 in total

1.  Cross-Border Emergence of Escherichia coli Producing the Carbapenemase NDM-5 in Switzerland and Germany.

Authors:  Trinad Chakraborty; Mustafa Sadek; Yancheng Yao; Can Imirzalioglu; Roger Stephan; Laurent Poirel; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

2.  Characterization of Carbapenemase-Producing Klebsiella oxytoca in Spain, 2016-2017.

Authors:  María Pérez-Vazquez; Jesús Oteo-Iglesias; Pedro J Sola-Campoy; Hugo Carrizo-Manzoni; Verónica Bautista; Noelia Lara; Belén Aracil; Almudena Alhambra; Luis Martínez-Martínez; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

3.  Carbapenem-resistant Enterobacteriaceae dispersal from sinks is linked to drain position and drainage rates in a laboratory model system.

Authors:  P Aranega-Bou; R P George; N Q Verlander; S Paton; A Bennett; G Moore
Journal:  J Hosp Infect       Date:  2018-12-18       Impact factor: 3.926

4.  Diverse Vectors and Mechanisms Spread New Delhi Metallo-β-Lactamases among Carbapenem-Resistant Enterobacteriaceae in the Greater Boston Area.

Authors:  Nicole Pecora; Xiaomin Zhao; Kathleen Nudel; Maria Hoffmann; Ning Li; Andrew B Onderdonk; Deborah Yokoe; Eric Brown; Marc Allard; Lynn Bry
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

Review 5.  The Growing Threat of Antibiotic Resistance in Children.

Authors:  Rachel L Medernach; Latania K Logan
Journal:  Infect Dis Clin North Am       Date:  2018-03       Impact factor: 5.982

6.  Evaluation of the Amplidiag CarbaR+VRE Kit for Accurate Detection of Carbapenemase-Producing Bacteria.

Authors:  Saoussen Oueslati; Delphine Girlich; Laurent Dortet; Thierry Naas
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

7.  Activity of Ertapenem against Enterobacteriaceae in seven global regions-SMART 2012-2016.

Authors:  Sibylle H Lob; Meredith A Hackel; Daryl J Hoban; Katherine Young; Mary R Motyl; Daniel F Sahm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-12       Impact factor: 3.267

8.  Clinical and Demographic Characteristics of Patients With a New Diagnosis of Carriage or Clinical Infection With Carbapenemase-Producing Enterobacterales: A Retrospective Study.

Authors:  Assaf Adar; Hiba Zayyad; Maya Azrad; Kozita Libai; Ilana Aharon; Orna Nitzan; Avi Peretz
Journal:  Front Public Health       Date:  2021-02-05

9.  Dynamics of bla KPC-2 Dissemination from Non-CG258 Klebsiella pneumoniae to Other Enterobacterales via IncN Plasmids in an Area of High Endemicity.

Authors:  Ana M Rada; Elsa De La Cadena; Carlos Agudelo; Cesar Capataz; Nataly Orozco; Cristian Pallares; An Q Dinh; Diana Panesso; Rafael Ríos; Lorena Diaz; Adriana Correa; Blake M Hanson; Maria V Villegas; Cesar A Arias; Eliana Restrepo
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

10.  Community Origins and Regional Differences Highlight Risk of Plasmid-mediated Fluoroquinolone Resistant Enterobacteriaceae Infections in Children.

Authors:  Latania K Logan; Rachel L Medernach; Jared R Rispens; Steven H Marshall; Andrea M Hujer; T Nicholas Domitrovic; Susan D Rudin; Xiaotian Zheng; Nadia K Qureshi; Sreenivas Konda; Mary K Hayden; Robert A Weinstein; Robert A Bonomo
Journal:  Pediatr Infect Dis J       Date:  2019-06       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.